Avitas Wealth Management LLC Sells 149 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)

Avitas Wealth Management LLC lessened its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 28.1% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 382 shares of the biopharmaceutical company’s stock after selling 149 shares during the quarter. […]

Related Keywords

Canada ,China ,Andrewj Murphy ,Marion Mccourt ,Morgan Stanley ,Regeneron Pharmaceuticals Company Profile ,Quilter Plc ,Venturi Wealth Management ,Exchange Commission ,Regeneron Pharmaceuticals Stock Performance ,China Universal Asset Management Co ,Regeneron Pharmaceuticals ,Avitas Wealth Management ,Regeneron Pharmaceuticals Inc ,Quarter For Regeneron Pharmaceuticals ,Nasdaq ,Asset Management One Co ,Securities Exchange Commission ,Braun Stacey Associates Inc ,Cantor Fitzgerald ,Royal Bank ,News Ratings For Regeneron Pharmaceuticals Daily ,Free Report ,Wealth Management ,Management One ,Universal Asset Management ,Braun Stacey Associates ,Stacey Associates ,Get Free Report ,Visit Holdingschannel ,Regeneron Pharmaceuticals Daily ,